Adiponectin Protects Against Hyperoxic Lung Injury and Vascular Leak

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 399-414

  Sliman, Sean M ^a   Patel, Rishi B ^a   Cruff, Jason P ^a   Kotha, Sainath R ^a   Newland, Christie A ^a   Schrader, Carrie A ^a   Sherwani, Shariq I ^a   Gurney, Travis O ^a   Magalang, Ulysses J ^a   Parinandi, Narasimham L ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adiponectin; Barrier dysfunction; Cytoskeletal rearrangement; Hyperoxia; Hyperoxic lung damage; Lung vascular endothelium; Oxidative stress; Reactive oxygen species

Indexed keywords

MUS; MUS MUSCULUS;

ADIPONECTIN; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; BLOOD VESSEL; CATTLE; CELL HYPOXIA; CYTOSKELETON; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GENETICS; HUMAN; LIPID PEROXIDATION; LUNG; LUNG INJURY; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PERMEABILITY; TIGHT JUNCTION; TRANSGENIC MOUSE;

ADIPONECTIN; ANIMALS; BLOOD VESSELS; CATTLE; CELL HYPOXIA; CYTOSKELETON; ENDOTHELIAL CELLS; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LUNG; LUNG INJURY; MALE; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PERMEABILITY; REACTIVE OXYGEN SPECIES; TIGHT JUNCTIONS;

EID: 84886585238     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9330-1     Document Type: Article

References (67)

1. Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L., Seckl, J. R., & Flier, J. S. (2005). Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes, 54(4), 1023-1031.
2. Wiecek, A., Kokot, F., Chudek, J., & Adamczak, M. (2002). The adipose tissue-a novel endocrine organ of interest to the nephrologist. Nephrology, Dialysis, Transplantation, 17(2), 191-195.
3. Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92(3), 347-355.
4. Guerre-Millo, M. (2004). Adipose tissue and adipokines: For better or worse. Diabetes & Metabolism, 30(1), 13-19.
5. Chandran, M., Phillips, S. A., Ciaraldi, T., & Henry, R. R. (2003). Adiponectin: More than just another fat cell hormone? Diabetes Care, 26(8), 2442-2450.
6. Berg, A. H., Combs, T. P., & Scherer, P. E. (2002). ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends in Endocrinology & Metabolism, 13(2), 84-89.
7. Berg, A. H., & Scherer, P. E. (2005). Adipose tissue, inflammation, and cardiovascular disease. Circulation Research, 96(9), 939-949.
8. Ouchi, N., Kihara, S., Arita, Y., et al. (1999). Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation, 100(25), 2473-2476.
9. Goldstein, B. J., Scalia, R. G., & Ma, X. L. (2009). Protective vascular and myocardial effects of adiponectin. Nature Clinical Practice Cardiovascular Medicine, 6(1), 27-35.
10. Motoshima, H., Wu, X., Mahadev, K., & Goldstein, B. J. (2004). Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochemical and Biophysical Research Communications, 315(2), 264-271.
11. Mossalam, M., Jeong, J. H., Abel, E. D., Kim, S. W., & Kim, Y. H. (2008). Reversal of oxidative stress in endothelial cells by controlled release of adiponectin. Journal of Controlled Release, 130(3), 234-237.
12. Magalang, U. J., Rajappan, R., Hunter, M. G., et al. (2006). Adiponectin inhibits superoxide generation by human neutrophils. Antioxidants & Redox Signaling, 8(11-12), 2179-2186.
13. Otterbein, L. E., Otterbein, S. L., Ifedigbo, E., et al. (2003). MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. American Journal of Pathology, 163(6), 2555-2563.
14. Jackson, R. M. (1985). Pulmonary oxygen toxicity. Chest, 88(6), 900-905.
15. Parinandi, N. L., Kleinberg, M. A., Usatyuk, P. V., et al. (2003). Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. American Journal of Physiology Lung Cellular and Molecular Physiology, 284(1), L26-L38.
16. Tyurina, Y. Y., Tyurin, V. A., Kaynar, A. M., et al. (2010). Oxidative lipidomics of hyperoxic acute lung injury: Mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. American Journal of Physiology Lung Cellular and Molecular Physiology, 299(1), L73-L85.
17. Christofidou-Solomidou, M., & Muzykantov, V. R. (2006). Antioxidant strategies in respiratory medicine. Treatments in Respiratory Medicine, 5(1), 47-78.
18. McQuaid, K. E., & Keenan, A. K. (1997). Endothelial barrier dysfunction and oxidative stress: Roles for nitric oxide? Experimental Physiology, 82(2), 369-376.
19. Usatyuk, P. V., Parinandi, N. L., & Natarajan, V. (2006). Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. Journal of Biological Chemistry, 281(46), 35554-35566.
20. Usatyuk, P. V., Romer, L. H., He, D., et al. (2007). Regulation of hyperoxia-induced NADPH oxidase activation in human lung endothelial cells by the actin cytoskeleton and cortactin. Journal of Biological Chemistry, 282(32), 23284-23295.
21. Lum, H., & Roebuck, K. A. (2001). Oxidant stress and endothelial cell dysfunction. American Journal of Physiology-Cell Physiology, 280(4), C719-C741.
22. Varadharaj, S., Steinhour, E., Hunter, M. G., et al. (2006). Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: Regulation by MAP kinases. Cellular Signalling, 18(9), 1396-1407.
23. Hagele, T. J., Mazerik, J. N., Gregory, A., et al. (2007). Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. International Journal of Toxicology, 26(1), 57-69.
24. Combs, T. P., Pajvani, U. B., Berg, A. H., et al. (2004). A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology, 145(1), 367-383.
25. Udalov, S., Dumitrascu, R., Pullamsetti, S. S., et al. (2010). Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine, 10, 26.
26. Takeda, K., Okamoto, M., de Langhe, S., et al. (2009). Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease. Anatomical Record (Hoboken), 292(7), 1045-1061.
27. Wang, Y., Phelan, S. A., Manevich, Y., Feinstein, S. I., & Fisher, A. B. (2006). Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. American Journal of Respiratory Cell and Molecular Biology, 34(4), 481-486.
28. Magalang, U. J., Cruff, J. P., Rajappan, R., et al. (2009). Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Experimental and Clinical Endocrinology and Diabetes, 117(3), 129-134.
29. Sliman, S. M., Eubank, T. D., Kotha, S. R., et al. (2009). Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Molecular and Cellular Biochemistry, 333(1-2), 9-26.
30. 2+ and permeability. American Journal of Physiology, 274(5 Pt 1), L810-L819.
31. Patterson, C. E., Rhoades, R. A., & Garcia, J. G. (1992). Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. Journal of Applied Physiology, 72(3), 865-873.
32. Fu, P., Birukova, A. A., Xing, J., et al. (2009). Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. European Respiratory Journal, 33(3), 612-624.
33. Long, E. K., & Picklo, M. J. S. (2010). Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE. Free Radical Biology and Medicine, 49(1), 1-8.
34. Bogatcheva, N. V., & Verin, A. D. (2008). The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvascular Research, 76(3), 202-207.
35. Ammer, A. G., & Weed, S. A. (2008). Cortactin branches out: Roles in regulating protrusive actin dynamics. Cell Motility and the Cytoskeleton, 65(9), 687-707.
36. Fasano, A. (2000). Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Annals of the New York Academy of Sciences, 915, 214-222.
37. Xu, Y., Gong, B., Yang, Y., Awasthi, Y. C., Woods, M., & Boor, P. J. (2007). Glutathione-S-transferase protects against oxidative injury of endothelial cell tight junctions. Endothelium, 14(6), 333-343.
38. Okamura, D. M., & Himmelfarb, J. (2009). Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatric Nephrology, 24(12), 2309-2319.
39. Auten, R. L., Whorton, M. H., & Nicholas Mason, S. (2002). Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. American Journal of Respiratory Cell and Molecular Biology, 26(4), 391-397.
40. Esterbauer, H., & Cheeseman, K. H. (1990). Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods in Enzymology, 186, 407-421.
41. Janero, D. R. (1990). Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology and Medicine, 9(6), 515-540.
42. Patterson, C. E., & Rhoades, R. A. (1988). Protective role of sulfhydryl reagents in oxidant lung injury. Experimental Lung Research, 14(Suppl), 1005-1019.
43. Hotta, K., Funahashi, T., Arita, Y., et al. (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(6), 1595-1599.
44. Okamoto, Y., Kihara, S., Ouchi, N., et al. (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 106(22), 2767-2770.
45. Galic, S., Oakhill, J. S., & Steinberg, G. R. (2010). Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology, 316, 129-139.
46. Saugstad, O. D. (2003). Bronchopulmonary dysplasia-oxidative stress and antioxidants. Seminars in Neonatology, 8(1), 39-49.
47. Asikainen, T. M., & White, C. W. (2004). Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: Implications for antioxidant therapy. Antioxidants & Redox Signaling, 6(1), 155-167.
48. Gore, A., Muralidhar, M., Espey, M. G., Degenhardt, K., & Mantell, L. L. (2010). Hyperoxia sensing: From molecular mechanisms to significance in disease. Journal of Immunotoxicology, 7(4), 239-254.
49. Altemeier, W. A., & Sinclair, S. E. (2007). Hyperoxia in the intensive care unit: Why more is not always better. Current Opinion in Critical Care, 13(1), 73-78.
50. Zaher, T. E., Miller, E. J., Morrow, D. M., Javdan, M., & Mantell, L. L. (2007). Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. Free Radical Biology and Medicine, 42(7), 897-908.
51. Marnett, L. J. (2002). Oxy radicals, lipid peroxidation and DNA damage. Toxicology, 181-182, 219-222.
52. Parola, M., Bellomo, G., Robino, G., Barrera, G., & Dianzani, M. U. (1999). 4-hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications. Antioxidants & Redox Signaling, 1(3), 255-284.
53. Loiseaux-Meunier, M. N., Bedu, M., Gentou, C., Pepin, D., Coudert, J., & Caillaud, D. (2001). Oxygen toxicity: Simultaneous measure of pentane and malondialdehyde in humans exposed to hyperoxia. Biomedicine and Pharmacotherapy, 55(3), 163-169.
54. Nagato, A., Silva, F. L., Silva, A. R., et al. (2009). Hyperoxia-induced lung injury is dose dependent in wistar rats. Experimental Lung Research, 35(8), 713-728.
55. Frey, R. S., Ushio-Fukai, M., & Malik, A. B. (2009). NADPH oxidase-dependent signaling in endothelial cells: Role in physiology and pathophysiology. Antioxidants & Redox Signaling, 11(4), 791-810.
56. Carnesecchi, S., Deffert, C., Pagano, A., et al. (2009). NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. American Journal of Respiratory and Critical Care Medicine, 180(10), 972-981.
57. Vandenbroucke, E., Mehta, D., Minshall, R., & Malik, A. B. (2008). Regulation of endothelial junctional permeability. Annals of the New York Academy of Sciences, 1123, 134-145.
58. Cai, H. (2005). Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovascular Research, 68(1), 26-36.
59. Dudek, S. M., & Garcia, J. G. (2001). Cytoskeletal regulation of pulmonary vascular permeability. Journal of Applied Physiology, 91(4), 1487-1500.
60. Zhao, X., Alexander, J. S., Zhang, S., et al. (2001). Redox regulation of endothelial barrier integrity. American Journal of Physiology Lung Cellular and Molecular Physiology, 281(4), L879-L886.
61. Usatyuk, P. V., Vepa, S., Watkins, T., He, D., Parinandi, N. L., & Natarajan, V. (2003). Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxidants & Redox Signaling, 5(6), 723-730.
62. Langley, S. C., & Kelly, F. J. (1993). N-acetylcysteine ameliorates hyperoxic lung injury in the preterm guinea pig. Biochemical Pharmacology, 45(4), 841-846.
63. Brown, L. A., Perez, J. A., Harris, F. L., & Clark, R. H. (1996). Glutathione supplements protect preterm rabbits from oxidative lung injury. American Journal of Physiology, 270(3 Pt 1), L446-L451.
64. O'Donovan, D. J., & Fernandes, C. J. (2000). Mitochondrial glutathione and oxidative stress: Implications for pulmonary oxygen toxicity in premature infants. Molecular Genetics and Metabolism, 71(1-2), 352-358.
65. You, M., & Rogers, C. Q. (2009). Adiponectin: A key adipokine in alcoholic fatty liver. Experimental Biology and Medicine (Maywood), 234, 850-859.
66. Kawano, J., & Arora, R. (2009). The role of adiponectin in obesity, diabetes, and cardiovascular disease. Journal of Cardiometabolic syndrome, 4, 44-49.
67. van Klaveren, R. J., Dinsdale, D., Pype, J. L., Demedts, M., & Nemery, B. (1997). N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. American Journal of Physiology, 273(3 Pt 1), L548-L555.